An adjusted odds ratio for CAD was found to be 0.98 (95% CI, 0.97–0.99; p = 0.011) per 1% increase in VWF:CB activity, and 1.06 (95% CI, 1.03–1.09; p < 0.001) per 1% decrease in platelet adhesion after GPIb inhibition. This evidence concerns the gene VWF and coronary artery disorder.